Eva Hitchman

1.8k total citations
18 papers, 712 citations indexed

About

Eva Hitchman is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Eva Hitchman has authored 18 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Eva Hitchman's work include Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Celiac Disease Research and Management (3 papers). Eva Hitchman is often cited by papers focused on Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Celiac Disease Research and Management (3 papers). Eva Hitchman collaborates with scholars based in Austria, Slovakia and Canada. Eva Hitchman's co-authors include Edward Penner, Józefa Węsierska‐Gądek, Georg Sauermann, Pier Maria Battezzati, Pietro Invernizzi, Mauro Podda, Massimo Zuin, Helmut Denk, Péter Ferenci and B Dragosics and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Gastroenterology.

In The Last Decade

Eva Hitchman

18 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hitchman Austria 14 500 430 204 130 119 18 712
Chiara Quarneti Italy 13 582 1.2× 500 1.2× 169 0.8× 69 0.5× 207 1.7× 22 782
Cristina Crespi Italy 11 748 1.5× 705 1.6× 57 0.3× 56 0.4× 52 0.4× 26 912
Orrawadee Hanvivatvong Thailand 10 221 0.4× 162 0.4× 81 0.4× 74 0.6× 155 1.3× 20 542
Takashi Kamihira Japan 10 465 0.9× 302 0.7× 71 0.3× 61 0.5× 254 2.1× 18 637
Shuichi Terasaki Japan 11 316 0.6× 253 0.6× 67 0.3× 47 0.4× 142 1.2× 23 459
Kenichi Harada Japan 14 215 0.4× 162 0.4× 51 0.3× 105 0.8× 243 2.0× 24 572
Alexander I. Aspinall Canada 10 396 0.8× 287 0.7× 42 0.2× 77 0.6× 173 1.5× 16 632
E. Penner Austria 8 144 0.3× 157 0.4× 58 0.3× 31 0.2× 58 0.5× 14 343
Hideaki Miura Japan 9 231 0.5× 147 0.3× 73 0.4× 97 0.7× 59 0.5× 22 395
Maria Paola Simula Italy 11 92 0.2× 88 0.2× 61 0.3× 78 0.6× 48 0.4× 21 387

Countries citing papers authored by Eva Hitchman

Since Specialization
Citations

This map shows the geographic impact of Eva Hitchman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hitchman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hitchman more than expected).

Fields of papers citing papers by Eva Hitchman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hitchman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hitchman. The network helps show where Eva Hitchman may publish in the future.

Co-authorship network of co-authors of Eva Hitchman

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hitchman. A scholar is included among the top collaborators of Eva Hitchman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hitchman. Eva Hitchman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Węsierska‐Gądek, Józefa, Edward Penner, Pier Maria Battezzati, et al.. (2006). Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology. 43(5). 1135–1144. 139 indexed citations
2.
Invernizzi, Pietro, Pier Maria Battezzati, Sabine Oertelt‐Prigione, et al.. (2004). 544 Prognostic value of autoantibodies against proteins of nuclear pore complexes (anti-NPCS) in early primary biliary cirrhosis (PBC). Journal of Hepatology. 40. 159–160. 7 indexed citations
3.
Węsierska‐Gądek, Józefa, Herbert Lindner, Eva Hitchman, Bettina Sarg, & Edward Penner. (2002). Anti-SLA seropositive autoimmune hepatitis sera recognize distinct subunits of glutathione S-transferase: high prevalence of the Ya autoantigen.. PubMed. 48(3). 301–7. 2 indexed citations
4.
5.
Invernizzi, Pietro, Mauro Podda, Pier Maria Battezzati, et al.. (2001). Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. Journal of Hepatology. 34(3). 366–372. 116 indexed citations
6.
Węsierska‐Gądek, Józefa, Rudolf Grimm, Eva Hitchman, & Edward Penner. (1998). Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology. 114(2). 329–335. 52 indexed citations
7.
Węsierska‐Gądek, Józefa, et al.. (1996). Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology. 110(3). 840–847. 69 indexed citations
8.
Węsierska‐Gądek, Józefa, et al.. (1996). Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope. Human Antibodies. 7(4). 167–174. 13 indexed citations
9.
Węsierska‐Gądek, Józefa, et al.. (1995). Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210.. The Journal of Experimental Medicine. 182(4). 1159–1162. 45 indexed citations
10.
Węsierska‐Gądek, Józefa, et al.. (1995). Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis.. Acta Biochimica Polonica. 42(2). 197–200. 6 indexed citations
11.
Węsierska‐Gądek, Józefa, et al.. (1992). Nucleolar proteins B23 and C23 as target antigens in chronic graft- versus-host disease. Blood. 79(4). 1081–1086. 27 indexed citations
12.
Węsierska‐Gądek, Józefa, et al.. (1992). Nucleolar proteins B23 and C23 as target antigens in chronic graft- versus-host disease. Blood. 79(4). 1081–1086. 26 indexed citations
13.
Węsierska‐Gądek, Józefa, Edward Penner, Eva Hitchman, & Georg Sauermann. (1990). Antibodies to nuclear lamin C in chronic hepatitis delta virus infection. Hepatology. 12(5). 1129–1133. 20 indexed citations
14.
Penner, Edward, et al.. (1990). Autoantibodies against different histone hi subtypes in systemic lupus erythematosus sera. Arthritis & Rheumatism. 33(8). 1273–1278. 22 indexed citations
15.
Penner, Edward, et al.. (1989). Antibodies to nuclear Lamin proteins in liver Disease. Immunological Investigations. 18(1-4). 365–372. 3 indexed citations
16.
Penner, Edward, et al.. (1988). Antibodies to nuclear lamins in autoimmune liver disease. Clinical Immunology and Immunopathology. 49(1). 107–115. 50 indexed citations
17.
Dragosics, B, Péter Ferenci, Eva Hitchman, & Helmut Denk. (1987). Long-term follow-up study of asymptomatic hbsag-positive voluntary blood donors in austria: A clinical and histologic evaluation of 242 cases. Hepatology. 7(2). 302–306. 73 indexed citations
18.
Penner, Edward, Ingela Kindås-Mügge, Eva Hitchman, & Georg Sauermann. (1986). Nuclear antigens recognized by antibodies present in liver disease sera.. PubMed. 63(2). 428–33. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026